Skip to main content
. 2023 Sep 19;18(9):e0291645. doi: 10.1371/journal.pone.0291645

Fig 9. The IC50 value of common drugs for chemotherapy and targeted therapy.

Fig 9

(A) High risk score indicated a lower IC50 value of 5-fluorouracil, camptothecin, cyclophosphamide, docetaxel, gemcitabine, oxaliplatin, and paclitaxel in HCC. (B) HCC patients with high risk score had a lower IC50 value of afatinib, axitinib, crizotinib, dasatinib, erlotinib, gefitinib, and Osimertinib.